Phei Er Saw

Prof. Dr. Phei Er Saw

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2022 in Trends in Immunology
Verified
Journal Article
Closed access
JZJiahui Zhang
Jiahui Zhang
DHDi Huang
Di Huang
PSPhei Er Saw
Phei Er Saw
ESErwei Song
Erwei Song

6 May 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JCJiewen Chen
Jiewen Chen
XLXiyuan Liu
Xiyuan Liu
YZYi Zou
Yi Zou
JGJunli Gong
Junli Gong
ZGZhenhuang Ge
Zhenhuang Ge
ESErwei Song
Erwei Song
A high-fat diet (HFD) is a high-risk factor for the malignant progression of cancers through the disruption of the intestinal microbiota. However, the role of the HFD-related gut microbiota in cancer development remains unclear. This study found that obesity and obesity-related gut microbiota were associated with poor prognosis and advanced clinicopathological status in female patients with breast cancer. To investigate the impact of HFD-associated gut microbiota on cancer progression, we established various models, including HFD feeding, fecal microbiota transplantation, antibiotic feeding, and bacterial gavage, in tumor-bearing mice. HFD-related microbiota promotes cancer progression by generating polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs). Mechanistically, the HFD microbiota released abundant leucine, which activated the mTORC1 signaling pathway in myeloid progenitors for PMN-MDSC differentiation. Clinically, the elevated leucine level in the peripheral blood induced by the HFD microbiota was correlated with abundant tumoral PMN-MDSC infiltration and poor clinical outcomes in female patients with breast cancer. These findings revealed that the “gut–bone marrow–tumor” axis is involved in HFD-mediated cancer progression and opens a broad avenue for anticancer therapeutic strategies by targeting the aberrant metabolism of the gut microbiota.

16 February 2024 in Drug Delivery
Verified
Journal Article
Open access
MGMeeiChyn Goh
MeeiChyn Goh
MDMeng Du
Meng Du
WPWang Rui Peng
Wang Rui Peng
PSPhei Er Saw
Phei Er Saw
ZCZhiyi Chen
Zhiyi Chen
Burn injuries are prevalent and life-threatening forms that contribute significantly to mortality rates due to associated wound infections. The management of burn wounds presents substantial challenges. Hydrogel exhibits tremendous potential as an ideal alternative to traditional wound dressings such as gauze. This is primarily attributed to its three-dimensional (3D) crosslinked polymer network, which possesses a high water content, fostering a moist environment that supports effective burn wound healing. Additionally, hydrogel facilitates the penetration of loaded therapeutic agents throughout the wound surface, combating burn wound pathogens through the hydration effect and thereby enhancing the healing process. However, the presence of eschar formation on burn wounds obstructs the passive diffusion of therapeutics, impairing the efficacy of hydrogel as a wound dressing, particularly in cases of severe burns involving deeper tissue damage. This review focuses on exploring the potential of hydrogel as a carrier for transdermal drug delivery in burn wound treatment. Furthermore, strategies aimed at enhancing the transdermal delivery of therapeutic agents from hydrogel to optimize burn wound healing are also discussed.

1 January 2020 in Theranostics
Verified
Journal Article
Open access
SLSenlin Li
Senlin Li
HLHuiru Li
Huiru Li
XXXiaoding Xu
Xiaoding Xu
PSPhei Er Saw
Phei Er Saw
LZLei Zhang
Lei Zhang
Liver is the principal detoxifying organ and metabolizes various compounds that produce free radicals (FR) constantly. To maintain the oxidative/antioxidative balance in the liver, antioxidants would scavenge FR by preventing tissue damage through FR formation, scavenging, or by enhancing their decomposition. The disruption of this balance therefore leads to oxidative stress and in turn leads to the onset of various diseases. Supplying the liver with exogeneous antioxidants is an effective way to recreate the oxidative/antioxidative balance in the liver homeostasis. Nevertheless, due to the short half-life and instability of antioxidants in circulation, the methodology for delivering antioxidants to the liver needs to be improved. Nanocarrier mediated delivery of antioxidants proved to be an ingenious way to safely and efficiently deliver a high payload of antioxidants into the liver for circumventing liver diseases. The objective of this review is to provide an overview of the role of reactive oxygen species (oxidant) and ROS scavengers (antioxidant) in liver diseases. Subsequently, current nanocarrier mediated antioxidant delivery methods for liver diseases are discussed.

1 January 2022 in Biomaterials
Verified
Journal Article
Closed access
SCShuwen Cao
Shuwen Cao
PSPhei Er Saw
Phei Er Saw
QSQian Shen
Qian Shen
RLRong Li
Rong Li
YLYun Liu
Yun Liu
XXXiaoding Xu
Xiaoding Xu

6 July 2020 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
ZCZhong Chen
Zhong Chen
CLChuang-Xin Lin
Chuang-Xin Lin
BSBin Song
Bin Song
CLChang-Chuan Li
Chang-Chuan Li
JQJun-Xiong Qiu
Jun-Xiong Qiu
YDYue Ding
Yue Ding
Spermidine has been known to inhibit the production of pro-inflammatory cytokines. However, there are no reports about anti-inflammatory effects of spermidine on osteoarthritis (OA). Herein, we examined whether OA progression could be delayed by intraperitoneal injection (i.p.) of spermidine in the anterior cruciate ligament transection (ACLT) and TNF-α induced arthritis (TIA) mouse models. During the process, human FLS cells (H-FLS) were used to investigate the potential ubiquitination mechanism of spermidine-mediated RIP1 in TNF-α-induced NF-κB/p65 signaling. We found that spermidine attenuated synovitis, cartilage degeneration and osteophyte formation, resulting in substantially lower OARSI scores and TNF-α scores in spermidine-treated ACLT and TIA mice. In terms of the mechanism, 9 μM spermidine did not affect the viability, proliferation, cell cycle and apoptosis of H-FLS, and exerted inhibitory effects by activating CYLD-mediated RIP1 deubiquitination on TNF-α-induced NF-κB/p65 signaling in H-FLS. From these data, we can conclude that spermidine attenuates OA progression by the inhibition of TNF-α-induced NF-κB pathway via the deubiquitination of RIP1 in FLS. Therefore, intake of spermidine could be a potential therapy for preventing OA.